Health Catalyst, a prominent provider of data and analytics technology and services to healthcare organizations, recently announced the successful completion of its acquisition of Lumeon Limited, a digital health company focused on automating care orchestration processes to improve care coordination in provider organizations. This acquisition is expected to enhance Health Catalyst’s core focus on clinical improvement and ambulatory operations, as well as support its Tech-Enabled Managed Services partnerships.
Lumeon’s Care Orchestration technology is utilized by leading providers in the U.S. and the United Kingdom to streamline processes, reduce costs, optimize staff time, increase revenue, and enhance patient safety. By combining Lumeon’s platform with advanced analytics, AI, and Health Catalyst Ignite™ data processing capabilities, Health Catalyst aims to make the platform more intelligent and provide valuable insights to healthcare providers seeking to transform clinical care.
The CEO of Health Catalyst, Dan Burton, expressed excitement about the collaboration with Lumeon and their shared mission of enabling data-informed healthcare improvement. He highlighted the importance of effective care management in a patient’s clinical care journey and how Lumeon’s Care Orchestration will complement Health Catalyst’s existing technology and services, offering enhanced analytics insights to providers.
Robbie Hughes, CEO of Lumeon, emphasized the potential of combining Health Catalyst’s AI platform with Care Orchestration technology to automate clinical actions, ensuring that data-driven insights translate into personalized care processes for patients and care teams. This collaboration is expected to accelerate the transformation of healthcare through data-driven decision-making.
The acquisition was funded by Health Catalyst using a combination of stock and cash. Additional details can be found in Health Catalyst’s Quarterly Report on Form 10-Q for the fiscal quarter ending June 30, 2024, which was filed with the Securities and Exchange Commission on August 7, 2024.
Health Catalyst envisions a future where all healthcare decisions are data-informed, and this acquisition of Lumeon is a significant step towards achieving that vision. By leveraging Lumeon’s Care Orchestration technology and integrating it with advanced analytics, Health Catalyst aims to empower healthcare organizations to improve patient care, operational efficiency, and financial outcomes.
For more information about Health Catalyst and Lumeon’s acquisition, please refer to the company’s official communications and SEC filings.